Bayanbold Khaliunaa, Younger Georgianne, Darbro Benjamin, Sidhu Alpa
Free Radical Radiation Biology, Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Division of Medical Genetics and Genomics, The Stead Family Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Case Rep Genet. 2023 Nov 1;2023:1692422. doi: 10.1155/2023/1692422. eCollection 2023.
Bromodomain and PHD finger containing 1 ()-related neurodevelopmental disorder is characterized by intellectual disability, developmental delay, hypotonia, dysmorphic facial features, ptosis, and blepharophimosis. Both and inherited pathogenic variants have been previously reported in association with this disorder. We report two affected female siblings with a novel variant in c.2420_2433del (p.Q807Lfs27) identified through whole-exome sequencing. Their history of mild intellectual disability, speech delay, attention deficient hyperactivity disorder (ADHD), and ptosis align with the features previously reported in the literature. The absence of the variant in parental buccal samples provides evidence of a frameshift pathogenic variant, most likely as a result of parental gonadal mosaicism, which has not been previously reported. The frameshift pathogenic variant reported here lends further support to haploinsufficiency as the underlying mechanism of disease. We review the literature, compare the clinical features seen in our patients with others reported, and explore the possibility of genotype-phenotype correlation based on the location of pathogenic variants in . Our study helps to summarize available knowledge and report the first case of a frameshift pathogenic variant in in two siblings with this neurodevelopmental disorder.
含溴结构域和PHD结构域蛋白1相关神经发育障碍的特征为智力残疾、发育迟缓、肌张力减退、面部畸形、上睑下垂和睑裂狭小。此前已有报道称该疾病与 和遗传性致病变异有关。我们报告了两名受影响的女性同胞,通过全外显子测序鉴定出 基因存在一种新的变异,即c.2420_2433del(p.Q807Lfs27)。她们轻度智力残疾、语言发育迟缓、注意力缺陷多动障碍(ADHD)和上睑下垂的病史与文献中先前报道的特征相符。在父母的颊黏膜样本中未检测到该变异,这为 基因移码致病变异提供了证据,很可能是由于父母的生殖腺嵌合现象,此前尚未有过相关报道。此处报道的移码致病变异进一步支持了单倍剂量不足作为疾病潜在机制的观点。我们回顾了文献,将我们患者的临床特征与其他报道的患者进行了比较,并基于 基因致病变异的位置探讨了基因型与表型相关性的可能性。我们的研究有助于总结现有知识,并报告了首例在患有这种神经发育障碍的两名同胞中发现的 基因移码致病变异。